Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
life sciences
national blog main
alprazolam
amgen
biopharma
boston
boston top stories
cgrp inhibitors
chronic migraine
clinical trials
colucid pharmaceuticals
deals
drug enforcement administration
duchenne
eli lilly
europe blog main
europe top stories
fda
indiana
indiana blog main
indiana top stories
lasmiditan
licensing
m&a
migraine research foundation
muscular dystrophy
national top stories
raleigh-durham blog main
raleigh-durham top stories
roche
sarepta therapeutics
teva pharmaceutical
triptans
What
approval
2
×
fda
second
2
×
won
acute
addresses
betting
billion
biopharma
causes
condition
deal
decades
drug
duchenne
eli
friday
gene
giant
giving
historic
lasmiditan
lilly
lilly’s
medication
medicine
migraine
new
oks
pharmaceutical
puts
recently
rna
roche
sarepta
swiss
therapeutics
therapy
Language
unset
Current search:
approval
×
biotech
×
second
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades